Stay updated on Pembrolizumab for Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Meningioma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision of Study Documents updated from v3.3.3 to v3.3.4; this appears to be a minor administrative update with no impact on eligibility criteria, trial results, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:35:21.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added a Massachusetts Locations section listing study sites (Dana-Farber Cancer Institute and Massachusetts General Hospital). Removed the separate Massachusetts Locations subsection and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:10:07.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision from v3.3.1 to v3.3.2, with no visible changes to study data or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:26:01.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Publications From PubMed description updated to say publications are automatically filled in from PubMed and may not be about the study, and the revision label updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:06:45.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Removed the government funding notice about operating status and delays, which was previously displayed at the top of the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:06:20.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Observed changes are non-significant, limited to metadata timestamps and minor layout adjustments; no core content, eligibility criteria, or study outcomes were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:44:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Meningioma Clinical Trial page.